[HTML][HTML] Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers–A multicentre cross-sectional study

…, S Güsewell, T Egger, OB Leal-Neto, J Sumer… - Clinical Microbiology …, 2021 - Elsevier
Objectives Protecting healthcare workers (HCWs) from coronavirus disease-19 (COVID-19)
is critical to preserve the functioning of healthcare systems. We therefore assessed …

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study

PP Kohler, CR Kahlert, J Sumer, D Flury… - Infection Control & …, 2021 - cambridge.org
In this prospective cohort of 1,012 Swiss hospital employees, 3 different assays were used
to screen serum for SARS-CoV-2 antibodies. Seropositivity was 1%; the positive predictive …

[HTML][HTML] Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A …

…, IAFM Heijnen, M Trendelenburg, R Thoma, J Sumer… - Trials, 2021 - Springer
Objectives Conestat alfa, a recombinant human C1 esterase inhibitor, is a multi-target inhibitor
of inflammatory cascades including the complement, the kinin-kallikrein and the contact …

[HTML][HTML] Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults—A randomized blinded controlled trial

J Sumer, K Keckeis, G Scanferla, M Frischknecht… - Frontiers in …, 2023 - frontiersin.org
Background: Echinacea purpurea has clinical antiviral activity against respiratory viruses
and modulates immune functions. Here we compared higher doses of new Echinacea …

SPECT/CT in patients with lower back pain after lumbar fusion surgery

J Sumer, D Schmidt, P Ritt, M Lell, R Forst… - Nuclear medicine …, 2013 - journals.lww.com
Objective The aim of the study was to investigate the incremental diagnostic value of skeletal
hybrid imaging with single-photon emission computed tomography and X-ray computed …

[HTML][HTML] Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

…, M Trendelenburg, R Thoma, J Sumer… - Frontiers in …, 2023 - frontiersin.org
… Trendelenburg 1,3,4 Reto Thoma Reto Thoma 5 Johannes Sumer Johannes Sumer 5
Adri n Camacho-Ortiz Adrián Camacho-Ortiz 6 Marcelo R. Bacci Marcelo R. Bacci 7 Lars C. …

[HTML][HTML] Digital SARS-CoV-2 detection among hospital employees: participatory surveillance study

…, T Egger, M Schlegel, D Flury, J Sumer… - JMIR Public Health …, 2021 - publichealth.jmir.org
Background: The implementation of novel techniques as a complement to traditional disease
surveillance systems represents an additional opportunity for rapid analysis. Objective: The …

[HTML][HTML] An unusual case of multiple hepatic and pulmonary abscesses caused by Aggregatibacter aphrophilus in a young man: a case report

J Sumer, S Haller, M Sawatzki, J Kellner… - Journal of Medical Case …, 2021 - Springer
Background Aggregatibacter aphrophilus, formerly known as Haemophilus aphrophilus,
belongs to the HACEK organisms, a group of pathogens classically associated with infectious …

[HTML][HTML] Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort

J Sumer, D Flury, CR Kahlert, NJ Mueller… - … Journal of Public …, 2022 - ssph-journal.org
During the COVID-19 pandemic, few scientific congresses have been held on-site. We
prospec-tively evaluated the safety concept of the congress of the Swiss Societies of Infectious …

[HTML][HTML] Safety evaluation of a medical congress held during the COVID-19 pandemic–a prospective cohort

D Flury, J Sumer, WC Albrich, CR Kahlert, NJ Mueller… - 2021 - europepmc.org
Background: Worldwide, scientific congresses are cancelled because of the COVID-19
pandemic. Yet, scientific exchange is more important than ever, especially for infectious diseases …